Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/31/2009US20090324580 Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases
12/31/2009US20090324577 6-11 Bicyclic Ketolide Derivatives
12/31/2009US20090324570 Photostabilization of Retinoids with Alkoxycrylene Compounds
12/31/2009US20090324569 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
12/31/2009US20090324566 T-Cell Receptor and Nucliec Acid Encoding the Receptor
12/31/2009US20090324562 Defensin Proteins
12/31/2009US20090324558 Transdiscal administration of cycline compounds
12/31/2009US20090324553 Chimeric Viral Envelopes
12/31/2009US20090324551 Tlr agonists
12/31/2009US20090324546 Method for modulating gene expression by modifying the cpg content
12/31/2009US20090324545 Polymorphic forms of (s)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl carbamate
12/31/2009US20090324544 Substituted cyclic pyrrolidine derivatives
12/31/2009US20090324543 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
12/31/2009US20090324542 optic neuritis; fingolimod or 2-amino-2-{2-[4-(1-oxo-5-phenylpentyl)phenyl]ethyl}propane-1,3-diol or salts as SP1 agonist
12/31/2009US20090324540 Compounds and compositions for delivering active agents
12/31/2009US20090324537 Polymeric Materials as Stomach Filler and Their Preparation
12/31/2009US20090324536 Antimicrobial polymers and coatings
12/31/2009US20090324511 Compounds, Compositions and Methods
12/31/2009US20090324510 Drug combinations for the treatment of respiratory tract diseases
12/31/2009US20090324507 RNAi-Mediated Inhibition of Spleen Tyrosine Kinase-Related Inflammatory Conditions
12/31/2009US20090324495 Compounds and methods for enzyme-mediated tumor imaging and therapy
12/31/2009US20090324489 Wortmannin conjugates and uses thereof
12/31/2009US20090320845 Method of demand valve oxygen therapy for rapid abort of cluster headache
12/31/2009DE202006020710U1 Zusammensetzungen mit Rosiglitazonmaleat Compositions with rosiglitazone maleate
12/31/2009DE102008031040A1 Use of 2-aminopyrimidine derivatives for the treatment of organ transplantation
12/31/2009DE102008031039A1 Use of N-phenylquinazolin-4-amine derivatives as receptor tyrosine kinase inhibitor for accompanying treatment of organ transplantations
12/31/2009DE102008031038A1 Use of 2-indolinone derivatives for the treatment of organ transplantation
12/31/2009DE102008031037A1 Use of 2-aminopyrimidine derivatives as receptor tyrosine kinase inhibitor for accompanying treatment of organ transplantations
12/31/2009DE102008031036A1 Use of 4-aminothiazolpyrimidine derivatives for the treatment of associated organ transplants
12/31/2009DE102008031035A1 Use of urea derivatives as receptor tyrosine kinase inhibitor for accompanying treatment of organ transplantations
12/31/2009DE102008030207A1 Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung Substituted 7-Sulfanylmethyl-, 7 Sulfinylmethyl- and 7-sulfonylmethyl-indoles and their use
12/31/2009DE102008030206A1 3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung 3 Cyanoalky- and 3-hydroxy-indoles and their use
12/31/2009DE102008030091A1 Uracilderivate und deren Verwendung Uracil derivatives, and their use
12/31/2009DE102008030046A1 Preparation of tablets comprising polyallylamine polymer, useful for treating e.g. hyperphosphatemia, comprises mixing polyallylamine polymer and additives, compacting to slug, granulating the slug and compressing the granules into tablets
12/31/2009DE102008029460A1 Taxifolinderivate zur Prophylaxe und Behandlung von neurologischen und psychiatrischen Störungen des zentralen Nervensystems Taxifolinderivate for the prophylaxis and treatment of neurological and psychiatric disorders of the central nervous system
12/31/2009CA2724607A1 Method and composition for skin inflammation and discoloration
12/30/2009WO2009158719A2 Methods and compositions for treating disorders
12/30/2009WO2009158713A1 Methods of using a methylxanthine compound
12/30/2009WO2009158687A1 Dermal delivery
12/30/2009WO2009158625A2 Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders
12/30/2009WO2009158587A1 Method for treating pulmonary diseases using rho kinase inhibitor compounds
12/30/2009WO2009158584A1 Dual adhesive technology
12/30/2009WO2009158571A1 Heteroaryl compounds and uses thereof
12/30/2009WO2009158526A2 Methods of reducing cellular proliferation by inhibiting acsvl3
12/30/2009WO2009158516A1 Schweinfurthin analogues
12/30/2009WO2009158499A2 Prevention of bacterial growth and biofilm formation by ligands that act on cannabinoidergic systems
12/30/2009WO2009158487A2 Treatment of nephrolithiasis and urolithiasis using 1,2,3,4,6-penta-o-galloyl-beta-d-glucose (pgg)
12/30/2009WO2009158473A1 5- and 6-membered heterocyclic compounds
12/30/2009WO2009158467A2 Di-substituted phenyl compounds
12/30/2009WO2009158452A1 Piperidinyl derivative as a modulator of chemokine receptor activity
12/30/2009WO2009158447A2 Materials and methods for suppressing and/or treating neurofibroma and related tumors
12/30/2009WO2009158446A2 Crystalline forms of ((((4-((5-(cyclopropylcarbamoyl)-2-methylphenyl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbonyl)(propyl)carbamoyl)oxy)methyl (4-(phosphonooxy)phenyl)acetate, method of preparation and use thereof
12/30/2009WO2009158430A1 (6s)-5-methyltetrahydrofolic acid for therapy of tissue injury
12/30/2009WO2009158426A1 6-substituted phenoxychroman carboxylic acid derivatives
12/30/2009WO2009158407A1 Iontophoretic delivery of curcumin and curcumin analogs for the treatment of alzheimer's disease
12/30/2009WO2009158396A1 Diketopiperidine derivatives as hiv attachment inhibitors
12/30/2009WO2009158394A1 Diketo azolopiperidines and azolopiperazines as anti-hiv agents
12/30/2009WO2009158393A1 1, 2 disubstituted heterocyclic compounds
12/30/2009WO2009158387A2 Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
12/30/2009WO2009158384A1 Methods and kits for the treatment inhibition, and maintenance of gastrointestinal disorders
12/30/2009WO2009158381A1 Novel psymberin derivatives, compositions, and their use as antineoplastic agents
12/30/2009WO2009158380A1 Cyclopentathiophene modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof
12/30/2009WO2009158377A1 Salts of methyl 2-((r))-(3-chlorophenyl)((r)-1-((s)-2-(methylamino)-3((r)-tetrahydro-2h-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate
12/30/2009WO2009158376A1 Inhibitors of akt activity
12/30/2009WO2009158375A1 Aza-cylic indole- 2 -carboxamides and methods of use thereof
12/30/2009WO2009158374A2 Inhibitors of akt activity
12/30/2009WO2009158373A1 Inhibitors of akt activity
12/30/2009WO2009158372A1 Inhibitors of akt activity
12/30/2009WO2009158371A1 Inhibitors of akt activity
12/30/2009WO2009158300A1 Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
12/30/2009WO2009158248A2 Method and compositions for improving skin and body appearance
12/30/2009WO2009158144A1 Method and composition for dermatoses
12/30/2009WO2009158032A1 Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
12/30/2009WO2009158031A2 Methods and compositions for therapeutic treatment
12/30/2009WO2009158026A1 Hydrazonamide compounds that modulate hsp90 activity
12/30/2009WO2009158011A1 Alkynyl alcohols as kinase inhibitors
12/30/2009WO2009158007A2 Methods and compositions for therapeutic treatment
12/30/2009WO2009158005A1 Benzazepinone compounds
12/30/2009WO2009157938A1 A2b adenosine receptor antagonists for treating cancer
12/30/2009WO2009157886A1 Antitumoral, antioxidant and immunomodulatory composite agent
12/30/2009WO2009157880A1 Pyrazine substituted purines
12/30/2009WO2009157860A1 New heterocyclic carboxamides for use as thrombin inhibitors
12/30/2009WO2009157858A1 Use of cyclolignans for the treatment of a hyperactive immune system
12/30/2009WO2009157801A1 Method for injecting an anesthetic into tissues
12/30/2009WO2009157799A1 Agent for treating and preventing oncological diseases and a method for the use of said agent (variants)
12/30/2009WO2009157767A1 Nutritional composition for improving the mammalian immune system
12/30/2009WO2009157759A1 Nutritional composition for improving the mammalian immune system
12/30/2009WO2009157628A1 Pharmaceutical composition for treating or preventing cancer comprising triazine compound as an active ingredient
12/30/2009WO2009157596A1 Ophthalmic composition for preventing and treating ocular diseases
12/30/2009WO2009157586A1 Transdermal patch containing fentanyl or salt thereof
12/30/2009WO2009157515A1 Pharmaceutical compositions
12/30/2009WO2009157505A1 Telomerase inhibitor
12/30/2009WO2009157423A1 Oxazolidinone derivative having fused ring
12/30/2009WO2009157418A1 Carboxylic acid compound
12/30/2009WO2009157399A1 Sulfonamide compound or salt thereof
12/30/2009WO2009157398A1 Therapeutic agent for inflammatory bowel disease
12/30/2009WO2009157397A1 Therapeutic agent for intestinal tract injury accompanying administration of a non-steroid anti-inflammatory agent
12/30/2009WO2009157396A1 Therapeutic agent for spinal canal stenosis
12/30/2009WO2009157377A1 Buccal anaesthetic
12/30/2009WO2009157196A1 Amide compound
1 ... 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 ... 7860